Status:
COMPLETED
Remote Ischemic Conditioning in Oncology
Lead Sponsor:
Children's Hospital Medical Center, Cincinnati
Conditions:
Participants Undergoing Anthracycline Chemotherapy
Eligibility:
All Genders
11+ years
Phase:
NA
Brief Summary
This is a feasibility study at a single site, Cincinnati Children's Hospital Medical Center. Patients undergoing anthracycline chemotherapy for Hodgkin disease and soft-tissue and bone sarcoma who mee...
Eligibility Criteria
Inclusion
- Pediatric, adolescent, or young adult patients, 11 years of age or above.
- Able to tolerate upper arm blood pressure inflation.
Exclusion
- Previous diagnosis of cardiomyopathy (dilated, hypertrophic, restrictive, myocarditis) or congenital heart disease other than bicuspid aortic valve.
- Chronic kidney disease as defined as a pre-transplant GFR \<80
- Central line in both upper extremities.
- Known peripheral vascular disease or vasculitis.
- Platelet count less than 30,000.
- Known clotting disorder or hypercoagulability
- Non-English-speaking patients.
Key Trial Info
Start Date :
April 30 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 3 2024
Estimated Enrollment :
1 Patients enrolled
Trial Details
Trial ID
NCT04805346
Start Date
April 30 2021
End Date
May 3 2024
Last Update
September 26 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cincinnati Children's Hospital
Cincinnati, Ohio, United States, 45229